Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Basal Cell Carcinoma Clinical Trials
Basal Cell Carcinoma clinical trials are recruiting across 26 cities. Here are the cities with the most active studies:
About Basal Cell Carcinoma
Basal cell carcinoma is the most common type of skin cancer, arising from basal cells in the skin. While rarely fatal, it can be locally destructive if untreated. Treatment includes surgical excision, Mohs surgery, topical therapies, and hedgehog pathway inhibitors.
Clinical trials are advancing new treatments for basal cell carcinoma. Currently, 12 studies are recruiting a combined 918 participants across the United States. Research is being conducted by 12 organizations including Boston University, Philogen S.p.A., Dartmouth-Hitchcock Medical Center and 9 others.
2026 Basal Cell Carcinoma Research Landscape
As of July 2026, the basal cell carcinoma clinical trial landscape includes 12 actively recruiting studies across 26 cities in the United States. These studies are collectively seeking 918 participants, with an average enrollment target of 77 per study.
Research is being led by 12 different organizations, including Boston University, Philogen S.p.A., Dartmouth-Hitchcock Medical Center, Stamford Pharmaceuticals, Inc., Roswell Park Cancer Institute, and 7 others. The large number of sponsors reflects significant research interest and investment in basal cell carcinoma treatment advancement.
Geographically, basal cell carcinoma trials are most concentrated in Tampa, Florida (2 trials); Phoenix, Arizona (2 trials); Boston, Massachusetts (1 trial); Atlanta, Georgia (1 trial); Houston, Texas (1 trial) and 7 other cities.
Featured Basal Cell Carcinoma Studies
Highlighted recruiting studies for basal cell carcinoma, selected by enrollment size and research scope.
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
The investigators will compare the application of two different creams for the treatment of low-risk skin cancers-superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis). 5-Fluorouracil cream is currently FDA approved for the treatment of superficial basal cell carcinoma and is routinely used by dermatologists across the country and at Boston Medical Center (BMC) for SC...
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Open label, randomized study in patients with LaBCC not eligible or refusing surgery or radiation therapy according to the evaluation of a local interdisciplinary tumor board. The primary objective of the study is to evaluate the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF, the secondary objectives of this study are to evaluate efficacy, safety and pharmacokinetics of immunocytokines. A minimum ...
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
The primary objective of this study is the evaluation of the efficacy of the tissue oxygen imager based on PpIX DF in differentiating benign skin growth from non-melanoma skin cancer (NMSC).
Frequently Asked Questions About Basal Cell Carcinoma Clinical Trials
Are there basal cell carcinoma clinical trials near me?
Yes, there are 12 basal cell carcinoma clinical trials currently recruiting across 26+ cities in the United States, including Tampa, Florida; Phoenix, Arizona; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.
How do I join a basal cell carcinoma clinical trial?
To join a basal cell carcinoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are basal cell carcinoma clinical trials free?
Yes, participation in basal cell carcinoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of basal cell carcinoma treatments are being studied?
Current basal cell carcinoma clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 12 research organizations.
Is it safe to participate in basal cell carcinoma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov